CD62 Blockade with P-Selectin Glycoprotein Ligand-Immunoglobulin Fusion Protein Reduces Ischemia-Reperfusion Injury After Rat Intestinal Transplantation
Authors:
- Douglas G. FarmerDFDouglas G. Farmer
- Xiu-Da ShenXSXiu-Da Shen
- Farin AmersiFAFarin Amersi
- Dean AnselmoDADean Anselmo
- Jeffrey P. MaJMJeffrey P. Ma
- Bibo KeBKBibo Ke
- Feng GaoFGFeng Gao
- Sarah DrySDSarah Dry
- Susan FernandezSFSusan Fernandez
- Gray D. ShawGSGray D. Shaw
- Sue V. McDiarmidSMSue V. McDiarmid
- Ronald W. BusuttilRBRonald W. Busuttil
- 15 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 79 (1) , 44-51
Abstract
Intestinal transplantation (ITx) is severely limited by ischemia-reperfusion (I/R) injury. This study investigates I/R injury and ameliorates its consequences by using a recombinant protein targeted against selectins (recombinant P-selectin glycoprotein ligand-immunoglobulin [rPSGL-Ig]). An isogeneic model of ITx was undertaken with control animals (no therapy) and treatment animals (rPSGL-Ig). Survival was assessed. Separate groups underwent an analysis examining tissue at multiple time points after I/R injury including histopathology; myeloperoxidase staining; immunostaining for CD3 and ED2; polymerase chain reaction analysis of interleukin (IL)-8/cytokine-inducible neutrophil chemoattractant, IL1β, IL-6, interferon-γ, IL-2, IL-4, and IL10; and western blots for hemoxygenase-1, BCL-2, and BCL-xl. Standard statistical analysis was undertaken. Treatment with rPSGL-Ig resulted in significantly improved survival after ITx. Analysis demonstrated diminished injury on histopathology and reduced tissue infiltration of neutrophils and lymphocytes. Significant differences in the cytokine profile after ITx were seen between the two groups including the production of inflammatory cytokines at 24 hr and the Th1 and Th2 cytokines at 2 and 4 hr. Last, treatment resulted in increased production of hemoxygenase, BCL-2, and BCL-xl. The results of this investigation of I/R injury after ITx revealed that rPSGL-Ig treatment led to marked improvement in outcome. The mechanism of action seems to involve the blockade of neutrophil and lymphocyte infiltration leading to a decreased inflammatory response possibly driven by Th2 cytokines. The results not only lend insight into the mechanisms behind I/R injury after ITx but also demonstrate a potential therapeutic modality to ameliorate its consequences.Keywords
This publication has 39 references indexed in Scilit:
- IL-10 Increases Tissue Injury After Selective Intestinal Ischemia/ReperfusionAnnals of Surgery, 2003
- Role of cell adhesion molecules in leukocyte recruitment in the liver and gutInternational Journal of Experimental Pathology, 2003
- Fundamental and Distinct Roles of P-Selectin and LFA-1 in Ischemia/Reperfusion-Induced Leukocyte-Endothelium Interactions in the Mouse ColonAnnals of Surgery, 2002
- The T cell as a bridge between innate and adaptive immune systems: Implications for the kidneyKidney International, 2002
- T-Lymphocytes Modulate the Microvascular and Inflammatory Responses to Intestinal Ischemia-ReperfusionMicrocirculation, 2002
- Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestineGut, 2001
- Protection of Grafts by Hemoxygenase‐1 and its Toxic Product Carbon MonoxideAmerican Journal of Transplantation, 2001
- ACUTE MESENTERIC ISCHEMIA AND REPERFUSIONShock, 1999
- Production and Gene Expression of IL-8-Iike Cytokine GRO/CINC-1 in Rat Nasal MucosaActa Oto-Laryngologica, 1997
- Refined technique for intestinal transplantation in the ratMicrosurgery, 1991